Philogen | Sustainability Performance
Philogen is a biotechnology company specializing in the development of targeted therapeutics. The company focuses on addressing unmet medical needs through innovative solutions in the fields of oncology and autoimmune diseases.
1996
Italy
501 - 1,000 employees
Pharmaceuticals
$100M - 500M in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#3934
Overallⓘ#194
in Italyⓘ#91
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Governance
TargetsFinancial Data
Business performanceCapital & innovationAnalyst projections
Controversy level
- Philogen's financial position as a clinical-stage biopharmaceutical company involved significant R&D expenditures with no commercial revenue.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
4-6
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.